杨梅, 黄帅, 舒茂. MONALEESA-7研究:瑞波西利联合内分泌治疗激素受体阳性绝经前晚期乳腺癌的疗效分析[J]. 循证医学, 2023, 23(2): 78-82. DOI: 10.12019/j.issn.1671-5144.2023.02.003
    引用本文: 杨梅, 黄帅, 舒茂. MONALEESA-7研究:瑞波西利联合内分泌治疗激素受体阳性绝经前晚期乳腺癌的疗效分析[J]. 循证医学, 2023, 23(2): 78-82. DOI: 10.12019/j.issn.1671-5144.2023.02.003
    YANG Mei, HUANG Shuai, SHU Mao. MONALEESA-7 Study: Analysis of the Efficacy of Ribociclib Combined With Endocrine Therapy for Hormone Receptor Positive Premenopausal Advanced Breast Cancer[J]. Journal of Evidence-Based Medicine, 2023, 23(2): 78-82. DOI: 10.12019/j.issn.1671-5144.2023.02.003
    Citation: YANG Mei, HUANG Shuai, SHU Mao. MONALEESA-7 Study: Analysis of the Efficacy of Ribociclib Combined With Endocrine Therapy for Hormone Receptor Positive Premenopausal Advanced Breast Cancer[J]. Journal of Evidence-Based Medicine, 2023, 23(2): 78-82. DOI: 10.12019/j.issn.1671-5144.2023.02.003

    MONALEESA-7研究:瑞波西利联合内分泌治疗激素受体阳性绝经前晚期乳腺癌的疗效分析

    MONALEESA-7 Study: Analysis of the Efficacy of Ribociclib Combined With Endocrine Therapy for Hormone Receptor Positive Premenopausal Advanced Breast Cancer

    /

    返回文章
    返回